Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers

on behalf of IPMDS-Neuroimaging Study Group

Research output: Contribution to journalReview article

34 Scopus citations

Abstract

Molecular imaging has proven to be a powerful tool for investigation of parkinsonian disorders. One current challenge is to identify biomarkers of early changes that may predict the clinical trajectory of parkinsonian disorders. Exciting new tracer developments hold the potential for in vivo markers of underlying pathology. Herein, we provide an overview of molecular imaging advances and how these approaches help us to understand PD and atypical parkinsonisms.

Original languageEnglish
Pages (from-to)181-192
Number of pages12
JournalMovement Disorders
Volume32
Issue number2
DOIs
StatePublished - Feb 1 2017

Keywords

  • FDG
  • PET
  • Parkinson's disease
  • acetylcholine
  • amyloid
  • atypical parkinsonism
  • dopamine
  • serotonin
  • tau

Fingerprint Dive into the research topics of 'Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers'. Together they form a unique fingerprint.

  • Cite this